Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Anticancer Drugs. 2012 Nov;23(10):1054–1066. doi: 10.1097/CAD.0b013e32835739dd

Figure 1.

Figure 1

Effect of HDAC inhibition on NB growth and cell cycle in vitro. (A) In vitro cell proliferation was examined by MTS colorimetric assays. NBL-W-N cells were grown for 1–3 days in the presence or absence of VPA with varying concentrations as indicated. (B) In vitro cell proliferation was examined by MTS colorimetric assays. LA1-55n cells were grown for 1–3 days in the presence or absence of VPA with varying concentrations as indicated. (C) BrdU incorporation assay was performed in LA1-55n cells treated with various concentrations of VPA for 1 day. (D) BrdU incorporation assay was performed in LA1-55n cells treated with various concentrations of TSA for 1 day. * p<0.05 compared to control